Home/Filings/4/0001247741-05-000015
4//SEC Filing

GROOM JOHN 4

Accession 0001247741-05-000015

CIK 0000886163other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 6:05 PM ET

Size

6.9 KB

Accession

0001247741-05-000015

Insider Transaction Report

Form 4
Period: 2005-05-17
GROOM JOHN
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2005-05-17$5.81/sh+16,237$94,37816,237 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2005-05-1716,2370 total
    Exercise: $5.81From: 1996-05-17Exp: 2005-05-17Common Stock (16,237 underlying)
Footnotes (1)
  • [F1]The transaction is the exercise of a derivative security. No price applies.

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001185299

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 6:05 PM ET
Size
6.9 KB